🔎 Trials Near Me

Akèy › Kansè poumon › Ohio › Cleveland

Etid klinik pou Kansè poumon nan Cleveland, OH

26 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Ap rekriteFaz 3
  • MetroHealth Medical Center, Cleveland
  • Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Ap rekriteFaz 3
  • Case Western Reserve University, Cleveland
  • MetroHealth Medical Center, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi lwen
  • ak 1 plis
Laj 70 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Ap rekriteFaz 3
  • Case Western Reserve University, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi lwen
  • ak 2 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT04181060

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • University Hospitals Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Ap rekriteFaz 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • UH Minoff Health Center at Chagrin Highlands, Orange · 12 mi lwen
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06758401

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06618287

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Ap rekriteFaz 2
  • Research Site, Cleveland
Laj 18 a 95 · Tout sèks · Mizajou Sep 23, 2026 · NCT05061550

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Ap rekriteFaz 2/3
  • The Cleveland Clinic Cancer Center At Fairview Hospital, Moll Pavilion, Cleveland
  • Cleveland Clinic, Cleveland
  • Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06712316

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Ap rekriteFaz 2
  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07104630

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Ap rekriteFaz 2/3
  • University Hospitals Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07100080

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

Ap rekrite
  • University Hospital Cleveland Medical Center, Cleveland
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07824583

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Ap rekriteFaz 1/2
  • Case Western Reserve University, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT06287775

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05786924

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

Ap rekriteFaz 1/2
  • Case Western Reserve University, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07012031

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06343402

The Vanguard Study: Testing a New Way to Screen for Cancer

Ap rekriteVolontè an sante akeyi
  • Louis Stokes Cleveland VA Medical Center, Cleveland
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Ap rekriteFaz 3
  • University Hospitals Cleveland Medical Center, Cleveland
  • The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • Case Western Reserve University, Cleveland
  • UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi lwen
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05624996

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Ap rekriteFaz 1
  • University Hospital - Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07444814

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Ap rekriteFaz 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT06162221

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Ap rekriteEtid obsèvasyon
  • University Hospitals Seidman Cancer Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Feb 23, 2026 · NCT05974150

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Ap rekrite
  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Feb 19, 2026 · NCT02984761

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cleveland Clinic, Cleveland
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 24, 2025 · NCT06228326

Etid Kansè poumon nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.